Walvax

Walvax Biotechnology Co., Ltd. was founded in 2001. It is a high-tech biopharmaceutical enterprise specializing in human vaccines and other biotechnological drugs, integrating research and development, production, and sales. Walvax holds a leading position in the industry within the niche market of biotechnological drugs, particularly novel vaccines. In 2010, Walvax successfully went public on the Shenzhen Stock Exchange (Stock Code: 300142), becoming the first company from Yunnan Province to be listed on China's Growth Enterprise Market. After two decades of development, the company has built an excellent and diverse product pipeline, including two globally significant vaccine products—the 13-valent pneumococcal conjugate vaccine and the HPV vaccine. Additionally, Walvax has established a leading domestic vaccine R&D and industrialization platform, attracting a large pool of professional and managerial talents with expertise combining both Chinese and Western knowledge. The company has received support from several major national projects, including the "863 Program" and the "Major New Drug Development" science and technology special projects. Walvax has also formed close cooperative relationships with internationally renowned organizations such as the Bill & Melinda Gates Foundation. Currently, the company has seven marketed vaccine products (with ten specifications): Haemophilus influenzae type b conjugate vaccine, Group A and C meningococcal polysaccharide conjugate vaccine, Group A and C meningococcal polysaccharide vaccine, ACYW135 meningococcal polysaccharide vaccine, adsorbed diphtheria, tetanus, and acellular pertussis combined vaccine, 23-valent pneumococcal polysaccharide vaccine, and 13-valent pneumococcal polysaccharide conjugate vaccine. Walvax consistently upholds its mission of "ensuring every person is born healthy" by incorporating social responsibility into its development strategy and management practices. With a steadfast commitment to ensuring product quality and safety, Walvax remains true to its original aspirations, keeps pace with the times, and strives to achieve outstanding results worthy of society and the era.